Reversal of scopolamine-induced disruption of prepulse inhibition by clozapine in mice

Pharmacology Biochemistry and Behavior

Volumn 101, Issue 1, 2012, Pages 107-114

  Singer, Philipp ^a,b   Yee, Benjamin K ^a,b  

^a ETH ZURICH   (Switzerland)

^b LEGACY RESEARCH   (United States)

Author keywords

Clozapine; Mice; Muscarinic receptor; Prepulse inhibition; Schizophrenia; Scopolamine

Indexed keywords

CLOZAPINE; METHYLSCOPOLAMINE; SCOPOLAMINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; MALE; MOUSE; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; STARTLE REFLEX; STIMULUS; WILD TYPE;

ACOUSTIC STIMULATION; ANALYSIS OF VARIANCE; ANIMALS; ANTIPSYCHOTIC AGENTS; CLOZAPINE; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICE; MICE, INBRED C57BL; MUSCARINIC ANTAGONISTS; N-METHYLSCOPOLAMINE; REPRODUCIBILITY OF RESULTS; SCOPOLAMINE HYDROBROMIDE; STARTLE REACTION;

ANIMALIA; MUS; RATTUS;

EID: 84855802232     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2011.12.010     Document Type: Article

References (67)

1. A.K. Andrus, B.R. Marable, G.L. Dunbar, M.P. Reilly, and J.P. Maurissen Effects of intensity and type of prepulse stimulus on prepulse inhibition in scopolamine treated rats Pharmacol Biochem Behav 87 2007 481 488 (Pubitemid 47238404)
2. S. Barak Modeling cholinergic aspects of schizophrenia, focus on the antimuscarinic syndrome Behav Brain Res 204 2009 335 351
3. N.W. Bond Prenatal alcohol exposure and offspring hyperactivity, effects of scopolamine and methylscopolamine Neurobehav Toxicol Teratol 8 1986 287 292 (Pubitemid 16077107)
4. D.L. Braff, and M.A. Geyer Sensorimotor gating and schizophrenia, human and animal model studies Arch Gen Psychiatry 47 1990 181 188 (Pubitemid 20058094)
5. D.L. Braff, C. Grillon, and M.A. Geyer Gating and habituation of startle reflex in schizophrenic patients Arch Gen Psychiatry 49 1992 206 215
6. D.L. Braff, M.A. Geyer, and N.R. Swerdlow Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies Psychopharmacology 156 2001 234 258 (Pubitemid 32705488)
7. F.P. Bymaster, C.C. Felder, S. Ahmed, and D.L. McKinzie Muscarinic receptors as a target for drugs treating schizophrenia Curr Drug Targets CNS Neurol Disord 1 2002 163 181
8. F.P. Bymaster, C.C. Felder, E. Tzavara, G.G. Nomikos, D.O. Calligaro, and D.L. Mckinzie Muscarinic mechanisms of antipsychotic atypicality Prog Neuropsychopharmacol Biol Psychiatry 27 2003 1125 1143 (Pubitemid 37464958)
9. C.A. Chapman, J.S. Yeomans, C.D. Blaha, and J.R. Blackburn Increased striatal dopamine efflux follows scopolamine administered systemically or to the tegmental pedunculopontine nucleus Neuroscience 76 1997 177 186 (Pubitemid 26407947)
10. P.A. Csomor, B.K. Yee, B.B. Quednow, R.R. Stadler, J. Feldon, and F.X. Vollenweider The monotonic dependency of prepulse inhibition of the acoustic startle reflex on the intensity of the startle-eliciting stimulus Behav Brain Res 174 2006 143 150 (Pubitemid 44397186)
11. P.A. Csomor, B.K. Yee, F.X. Vollenweider, J. Feldon, T. Nicolet, and B.B. Quednow On the influence of baseline startle reactivity on the indexation of prepulse inhibition Behav Neurosci 122 2008 885 900
12. M.A. Davies, B.A. Compton-Toth, S.J. Hufeisen, H.Y. Meltzer, and B.L. Roth The highly efficacious actions of N-desmethylclozapine at muscarinic receptors are unique and not a common property of either typical or atypical antipsychotic drugs: is M1 agonism a pre-requisite for mimicking clozapine's actions? Psychopharmacology (Berl) 178 2005 451 460 (Pubitemid 40486985)
13. K.L. Davis, L.E. Hollister, P.A. Berger, and J.D. Barchas Cholinergic imbalance hypothesis of psychoses and movement disorders, strategies for evaluation Psychopharmacol Commun 1 1975 533 543
14. M. Davis, R.S. Mansbach, N.R. Swerdlow, S. Campeau, D.L. Braff, and M.A. Geyer Apomorphine disrupts the inhibition of acoustic startle induced by weak prepulses in rats Psychopharmacology (Berl) 1021 1990 1 4 (Pubitemid 20227519)
15. V. De Luca, H. Wang, A. Squassina, G.W. Wong, J. Yeomans, and J.L. Kennedy Linkage of M5 muscarinic and alpha7-nicotinic receptor genes on 15q13 to schizophrenia Neuropsychobiology 50 2004 124 127 (Pubitemid 39077830)
16. B. Dean, F.P. Bymaster, and E. Scarr Muscarinic receptors in schizophrenia Curr Mol Med 3 2003 419 426 (Pubitemid 36975101)
17. J.M. Doherty, V.L. Masten, S.B. Powell, R.J. Ralph, D. Klamer, and M.J. Low Contributions of dopamine D1, D2, and D3 receptor subtypes to the disruptive effects of cocaine on prepulse inhibition in mice Neuropsychopharmacology 33 2008 2648 2656
18. D.R. Drachman, and B.J. Sahakian The effects of cholinergic agents on human learning and memory A. Barbeau, J.H. Growden, R.J. Wurtman, Nutrition in the brain 1979 Raven New York 351 366
19. L. Eleore, J.C. López-Ramos, P.J. Yi, and J.M. Delgado-García The cognitive enhancer T-588 partially compensates the motor associative learning impairments induced by scopolamine injection in mice Behav Neurosci 121 2007 1203 1214
20. B.J. Everitt, and T.W. Robbins Central cholinergic systems and cognition Annu Rev Clin Psychol 48 1997 649 684 (Pubitemid 127485189)
21. M. Fendt, and M. Koch Cholinergic modulation of the acoustic startle response in the caudal pontine reticular nucleus of the rat Eur J Pharmacol 370 1999 101 107 (Pubitemid 29185095)
22. M.A. Geyer, and B. Ellenbroek Animal behavior models of the mechanisms underlying antipsychotic atypicality Prog Neuropsychopharmacol Biol Psychol 27 2003 1071 1079 (Pubitemid 37464953)
23. M.A. Geyer, K. Krebs-Thomson, D.L. Braff, and N.R. Swerdlow Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia. A decade in review Psychopharmacology (Berl) 156 2001 117 154 (Pubitemid 32702206)
24. F.K. Graham The more or less startling effects of weak prestimulation Psychophysiology 12 1975 238 248
25. H.S. Hoffman, and J.L. Searle Acoustic variables in the modification of startle reaction in the rat J Comp Physiol Psychol 60 1965 53 58
26. E. Hohnadel, K. Bouchard, and A.V. Terry Jr. Galantamine and donepezil attenuate pharmacologically induced deficits in prepulse inhibition in rats Neuropharmacology 52 2007 542 551 (Pubitemid 46123371)
27. C.K. Jones, and H.E. Shannon Effects of scopolamine in comparison with apomorphine and phencyclidine on prepulse inhibition in rats Eur J Pharmacol 391 2000 105 112 (Pubitemid 30138086)
28. C.K. Jones, and H.E. Shannon Muscarinic cholinergic modulation of prepulse inhibition of the acoustic startle reflex J Pharmacol Exp Ther 294 2000 1017 1023 (Pubitemid 30666854)
29. C.K. Jones, E.L. Eberle, D.B. Shaw, D.L. McKinzie, and H.E. Shannon Pharmacologic interactions between the muscarinic cholinergic and dopaminergic systems in the modulation of prepulse inhibition in rats J Pharmacol Exp Ther 312 2005 1055 1063 (Pubitemid 40293764)
30. M.B. Marchlewski Anticholinergic syndrome, avoiding misdiagnosis J Psychosoc Nurs Ment Health Serv 32 1994 22 24
31. M.-M. Mesulam, E.J. Mufson, B.H. Wainer, and A.I. Levey Central cholinergic pathways in the rat: an overview based on an alternative nomenclature (Ch1-Ch6) Neuroscience 10 1983 1185 1201 (Pubitemid 14178569)
32. E.S. Mitchell, and J.F. Neumaier 5-HT6 receptor antagonist reversal of emotional learning and prepulse inhibition deficits induced by apomorphine or scopolamine Pharmacol Biochem Behav 88 2008 291 298 (Pubitemid 350116256)
33. M.C. Olianas, C. Maullu, and P. Onali Mixed agonist-antagonist properties of clozapine at different human cloned muscarinic receptor subtypes expressed in Chinese hamster ovary cells Neuropsychopharmacology 20 1999 263 270 (Pubitemid 29067405)
34. A.M. Ouagazzal, F. Jenck, and J.L. Moreau Drug-induced potentiation of prepulse inhibition of acoustic startle reflex in mice, a model for detecting antipsychotic activity? Psychopharmacology (Berl) 156 2001 273 283 (Pubitemid 32702218)
35. E.K. Perry, and R.H. Perry Acetylcholine and hallucinations, disease-related compared to drug-induced alterations in human consciousness Brain Cogn 28 1995 240 258
36. P.J. Perry, D.C. Wilding, and R.P. Juhl Anticholinergic psychosis Am J Hosp Pharm 35 1978 725 728
37. S. Pietropaolo, P. Singer, J. Feldon, and B.K. Yee The postweaning social isolation in C57BL/6 mice, preferential vulnerability in the male sex Psychopharmacology (Berl) 197 2008 613 628
38. T.J. Raedler, F.P. Bymaster, R. Tandon, D. Copolov, and B. Dean Towards a muscarinic hypothesis of schizophrenia Mol Psychiatry 12 2007 232 246 (Pubitemid 46328501)
39. R.J. Ralph-Williams, V. Lehmann-Masten, and M.A. Geyer Dopamine D1 rather than D2 receptor agonists disrupt prepulse inhibition of startle in mice Neuropsychopharmacology 28 2003 108 118
40. T.W. Robbins Arousal systems and attentional processes Biol Psychol 45 1997 57 71 (Pubitemid 27110537)
41. H. Russig, W. Spooren, S. Durkin, J. Feldon, and B.K. Yee Apomorphine-induced disruption of prepulse inhibition that can be normalised by systemic haloperidol is insensitive to clozapine pretreatment Psychopharmacology (Berl) 175 2004 143 147 (Pubitemid 39222343)
42. P.R. Sanberg, M.A. Henault, S.H. Hagenmeyer-Houser, and K.H. Russell The topography of amphetamine and scopolamine-induced hyperactivity, toward an activity print Behav Neurosci 101 1987 131 133 (Pubitemid 17028963)
43. E. Scarr, and B. Dean Muscarinic receptors, do they have a role in the pathology and treatment of schizophrenia? J Neurochem 107 2008 1188 1195
44. H.E. Shannon, and S.C. Peters A comparison of the effects of cholinergic and dopaminergic agents on scopolamine-induced hyperactivity in mice J Pharmacol Exp Ther 255 1990 549 553
45. P. Singer, J. Feldon, K. Benjamin, and B.K. Yee Are DBA/2 mice associated with schizophrenia-like endophenotypes? A behavioural contrast with C57BL/6 mice Psychopharmacology (Berl) 206 2009 677 698
46. M.L. Sipos, V. Burchnell, and G. Galbicka Dose-response curves and time-course effects of selected anticholinergics on locomotor activity in rats Psychopharmacology (Berl) 147 1999 250 256 (Pubitemid 30010544)
47. M.L. Sipos, V. Burchnell, and G. Galbicka Effects of selected anticholinergics on acoustic startle response in rats Fundam Appl Toxicol 21 2001 95 101
48. K.J. Stanhope, N.R. Mirza, M.J. Bickerdike, J.L. Bright, N.R. Harrington, and M.B. Hesselink The muscarinic receptor agonist xanomeline has an antipsychotic-like profile in the rat J Pharmacol Exp Ther 299 2001 782 792
49. N. Swerdlow, and M.A. Geyer Prepulse inhibition of acoustic startle in rats after lesions of the pedunculopontine tegmental nucleus Behav Neurosci 107 1993 104 117 (Pubitemid 23187261)
50. N. Swerdlow, V.A. Keith, D.L. Braff, and M.A. Geyer Effects of spiperone, raclopride, SCH 23390 and clozapine on apomorphine inhibition of sensorimotor gating of the startle response in the rat J Pharmacol Exp Ther 256 1991 530 536
51. N.R. Swerdlow, D.L. Braff, and M.A. Geyer Animal models of deficient sensorimotor gating, what we know, what we think we know, and what we hope to know soon Behav Pharmacol 11 2000 185 204 (Pubitemid 30449750)
52. N.R. Swerdlow, M.A. Geyer, and D.L. Braff Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges Psychopharmacology (Berl) 156 2001 194 215 (Pubitemid 32702213)
53. M.G. Tadros, M.R. Mohamed, A.M. Youssef, G.M. Sabry, N.A. Sabry, and A.E. Khalifa Proapoptotic and prepulse inhibition (PPI) disrupting effects of Hypericum perforatum in rats J Ethnopharmacol 122 2009 561 566
54. M. Thomsen, G. Wortwein, A. Fink-Jensen, D.P. Woldbye, J. Wess, and S.B. Caine Decreased prepulse inhibition and increased sensitivity to muscarinic, but not dopaminergic drugs in M5 muscarinic acetylcholine receptor knockout mice Psychopharmacology (Berl) 192 2007 97 110 (Pubitemid 46673887)
55. M. Thomsen, J. Wess, B.S. Fulton, A. Fink-Jensen, and S.B. Caine Modulation of prepulse inhibition through both M(1) and M(4) muscarinic receptors in mice Psychopharmacology (Berl) 208 2010 401 416
56. E.T. Tzavara, F.P. Bymaster, R.J. Davis, M.R. Wade, and K.W. Perry Wess. M4 muscarinic receptors regulate the dynamics of cholinergic and dopaminergic neurotransmission: relevance to the pathophysiology and treatment of related CNS pathologies FASEB J 18 2004 1410 1412 (Pubitemid 39561597)
57. M. Ukai, A. Okuda, and T. Mamiya Effects of anticholinergic drugs selective for muscarinic receptor subtypes on prepulse inhibition in mice Eur J Clin Pharmacol 492 2004 183 187 (Pubitemid 38721370)
58. D.M. Weiner, H.Y. Meltzer, I. Veinbergs, E.M. Donohue, T.A. Spalding, and T.T. Smith The role of M1 muscarinic receptor agonism of N-desmethylclozapine in the unique clinical effects of clozapine Psychopharmacology (Berl) 177 2004 207 216 (Pubitemid 40109932)
59. N.J. Woolf, and L.L. Butcher Cholinergic systems of the rat brain. III. Projections from the pontomesencephalic tegmentum to the thalamus, tectum, basal ganglia, and basal forebrain Brain Res Bull 16 1986 603 637 (Pubitemid 16041624)
60. M.F. Wu, D.J. Jenden, M.D. Fairchild, and J.M. Siegel Cholinergic mechanisms in startle and prepulse inhibition, effects of the false cholinergic precursor N-aminodeanol Behav Neurosci 107 1993 306 316 (Pubitemid 23187282)
61. B.K. Yee, and J. Feldon Distinct forms of prepulse inhibition disruption distinguishable by the associated changes in prepulse-elicited reaction Behav Brain Res 204 2009 387 395
62. B.K. Yee, D.L. Chang, and J. Feldon The Effects of dizocilpine and phencyclidine on prepulse inhibition of the acoustic startle reflex and on prepulse-elicited reactivity in C57BL6 mice Neuropsychopharmacology 29 2004 1865 1877 (Pubitemid 39336798)
63. B.K. Yee, H. Russig, and J. Feldon Apomorphine-induced prepulse inhibition disruption is associated with a paradoxical enhancement of prepulse stimulus reactivity Neuropsychopharmacology 29 2004 240 248 (Pubitemid 38175143)
64. B.K. Yee, T. Chang, S. Pietropaolo, and J. Feldon The expression of prepulse inhibition of the acoustic startle reflex as a function of three pulse stimulus intensities, three prepulse stimulus intensities, and three levels of startle responsiveness in C57BL6/J mice Behav Brain Res 163 2005 265 276 (Pubitemid 41138061)
65. J.S. Yeomans Role of tegmental cholinergic neurons in dopaminergic activation, antimuscarinic psychosis and schizophrenia Neuropsychopharmacology 12 1995 3 16
66. J.S. Yeomans, D. Bosch, N. Alves, A. Daros, R.J. Ure, and S. Schmid GABA receptors and prepulse inhibition of acoustic startle in mice and rats Eur J Neurosci 31 2010 2053 2061
67. S.H. Zorn, S.B. Jones, K.M. Ward, and D.R. Liston Clozapine is a potent and selective muscarinic M4 receptor agonist Eur J Pharmacol 269 1994 R1 R2